Table 3.
Indications for Measuring Coronary Vascular Function as an Adjunct to Clinically Indicated Coronary Angiography
Condition | Invasive Diagnostic Management | Abbreviation |
---|---|---|
Current indications | ||
Angina | No obstructive coronary disease | INOCA |
Myocardial infarction | Infarction without culprit stenosis for which vasospastic angina is considered | MINOCA |
Cardiac arrest | In certain scenarios (ventricular arrhythmias, resuscitated cardiac arrest) for which no clear cardiac cause can be found and the patient is stabilized with normal LV function, no obstructive CAD, and normal ECG findings | VSA |
Future possibilities | ||
Angina | Suspected obstructive CAD | Pre-PCI |
Post-PCI | Post-PCI | |
Heart failure | Preserved systolic function | HFpEF |
After cardiac transplantation | ||
Myocardial infarction | Stratification of risk and prognosis | STEMI, NSTEMI |
No obstructive coronary disease | MINOCA |
CAD = coronary artery disease; ECG = electrocardiographic; HFpEF = heart failure with preserved ejection fraction; INOCA = ischemia with no obstructive coronary artery disease; LV = left ventricular; MINOCA = myocardial infarction with no obstructive coronary disease; NSTEMI = non–ST-segment elevation myocardial infarction; PCI = percutaneous coronary intervention; STEMI = ST-segment elevation myocardial infarction; VSA = vasospastic angina.